Year |
Citation |
Score |
2022 |
Molugu K, Battistini GA, Heaster TM, Rouw J, Guzman EC, Skala MC, Saha K. Label-Free Imaging to Track Reprogramming of Human Somatic Cells. Gen Biotechnology. 1: 176-191. PMID 35586336 DOI: 10.1089/genbio.2022.0001 |
0.33 |
|
2020 |
Walsh AJ, Mueller KP, Tweed K, Jones I, Walsh CM, Piscopo NJ, Niemi NM, Pagliarini DJ, Saha K, Skala MC. Classification of T-cell activation via autofluorescence lifetime imaging. Nature Biomedical Engineering. PMID 32719514 DOI: 10.1038/S41551-020-0592-Z |
0.302 |
|
2020 |
Sinha D, Steyer B, Shahi PK, Mueller KP, Valiauga R, Edwards KL, Bacig C, Steltzer SS, Srinivasan S, Abdeen A, Cory E, Periyasamy V, Siahpirani AF, Stone EM, Tucker BA, ... ... Saha K, et al. Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy. American Journal of Human Genetics. PMID 32707085 DOI: 10.1016/J.Ajhg.2020.06.011 |
0.311 |
|
2020 |
Shankar K, Capitini CM, Saha K. Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies. Stem Cell Research & Therapy. 11: 234. PMID 32546200 DOI: 10.1186/S13287-020-01741-4 |
0.39 |
|
2019 |
Molugu K, Harkness T, Carlson-Stevermer J, Prestil R, Piscopo NJ, Seymour SK, Knight GT, Ashton RS, Saha K. Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics. Biophysical Journal. PMID 31699335 DOI: 10.1016/J.Bpj.2019.10.014 |
0.46 |
|
2018 |
Mueller K, Carlson-Stevermer J, Saha K. Increasing the precision of gene editing , and . Current Opinion in Biomedical Engineering. 7: 83-90. PMID 31086832 DOI: 10.1016/J.Cobme.2018.08.006 |
0.342 |
|
2018 |
Steyer B, Cory E, Saha K. Developing precision medicine using scarless genome editing of human pluripotent stem cells. Drug Discovery Today. Technologies. 28: 3-12. PMID 30205878 DOI: 10.1016/J.Ddtec.2018.02.001 |
0.37 |
|
2018 |
Steyer B, Bu Q, Cory E, Jiang K, Duong S, Sinha D, Steltzer S, Gamm D, Chang Q, Saha K. Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection. Stem Cell Reports. PMID 29307579 DOI: 10.1016/J.Stemcr.2017.12.004 |
0.431 |
|
2017 |
Carlson-Stevermer J, Abdeen AA, Kohlenberg L, Goedland M, Molugu K, Lou M, Saha K. Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing. Nature Communications. 8: 1711. PMID 29167458 DOI: 10.1038/S41467-017-01875-9 |
0.318 |
|
2017 |
Piscopo NJ, Mueller KP, Das A, Hematti P, Murphy WL, Palecek SP, Capitini CM, Saha K. Bioengineering solutions for manufacturing challenges in CAR T cells. Biotechnology Journal. PMID 28840981 DOI: 10.1002/Biot.201700095 |
0.351 |
|
2017 |
Abdeen AA, Saha K. Manufacturing Cell Therapies Using Engineered Biomaterials. Trends in Biotechnology. PMID 28711155 DOI: 10.1016/J.Tibtech.2017.06.008 |
0.386 |
|
2017 |
Carlson-Stevermer J, Saha K. Genome Editing in Human Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1590: 165-174. PMID 28353269 DOI: 10.1007/978-1-4939-6921-0_12 |
0.424 |
|
2016 |
Li M, Zhao H, Ananiev GE, Musser M, Ness KH, Maglaque DL, Saha K, Bhattacharyya A, Zhao X. Establishment of reporter lines for detecting fragile X mental retardation (FMR1) gene reactivation in human neural cells. Stem Cells (Dayton, Ohio). PMID 27422057 DOI: 10.1002/Stem.2463 |
0.342 |
|
2016 |
Carlson-Stevermer J, Goedland M, Steyer B, Movaghar A, Lou M, Kohlenberg L, Prestil R, Saha K. High-Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells. Stem Cell Reports. 6: 109-120. PMID 26771356 DOI: 10.1016/J.Stemcr.2015.11.014 |
0.445 |
|
2016 |
Carlson-Stevermer J, Goedland M, Steyer B, Movaghar A, Lou M, Kohlenberg L, Prestil R, Saha K. 575. High Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells Molecular Therapy. 24: S229-S230. DOI: 10.1016/S1525-0016(16)33383-4 |
0.444 |
|
2016 |
Steyer B, Carlson-Stevermer J, Angenent-Mari N, Khalil A, Harkness T, Saha K. 335. High Content Analysis Platform for Optimization of Lipid Mediated CRISPR-Cas9 Delivery Strategies in Human Cells Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)33144-6 |
0.362 |
|
2015 |
Steyer B, Carlson-Stevermer J, Angenent-Mari N, Khalil A, Harkness T, Saha K. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells. Acta Biomaterialia. PMID 26747759 DOI: 10.1016/J.Actbio.2015.12.036 |
0.356 |
|
2015 |
Laperle A, Hsiao C, Lampe M, Mortier J, Saha K, Palecek SP, Masters KS. α-5 Laminin Synthesized by Human Pluripotent Stem Cells Promotes Self-Renewal. Stem Cell Reports. 5: 195-206. PMID 26235893 DOI: 10.1016/J.Stemcr.2015.06.009 |
0.427 |
|
2015 |
Harkness T, McNulty JD, Prestil R, Seymour SK, Klann T, Murrell M, Ashton RS, Saha K. High-Content Imaging with Micropatterned Multiwell Plates Reveals Influence of Cell Geometry and Cytoskeleton on Chromatin Dynamics. Biotechnology Journal. PMID 26097126 DOI: 10.1002/Biot.201400756 |
0.413 |
|
2014 |
Saha K, Hogle LF. Allying with donors to link health and medical information with stem cell lines can advance disease modeling while enhancing data access. Cell Stem Cell. 14: 559-60. PMID 24792113 DOI: 10.1016/J.Stem.2014.04.012 |
0.379 |
|
2014 |
Armond JW, Saha K, Rana AA, Oates CJ, Jaenisch R, Nicodemi M, Mukherjee S. A stochastic model dissects cell states in biological transition processes. Scientific Reports. 4: 3692. PMID 24435049 DOI: 10.1038/Srep03692 |
0.371 |
|
2014 |
Gajbhiye V, Escalante L, Chen G, Laperle A, Zheng Q, Steyer B, Gong S, Saha K. Drug-loaded nanoparticles induce gene expression in human pluripotent stem cell derivatives. Nanoscale. 6: 521-31. PMID 24232694 DOI: 10.1039/C3Nr04794F |
0.394 |
|
2014 |
Cordie T, Harkness T, Jing X, Carlson-Stevermer J, Mi HY, Turng LS, Saha K. Nanofibrous electrospun polymers for reprogramming human cells Cellular and Molecular Bioengineering. 7: 379-393. DOI: 10.1007/S12195-014-0341-Z |
0.393 |
|
2011 |
Saha K, Mei Y, Reisterer CM, Pyzocha NK, Yang J, Muffat J, Davies MC, Alexander MR, Langer R, Anderson DG, Jaenisch R. Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proceedings of the National Academy of Sciences of the United States of America. 108: 18714-9. PMID 22065768 DOI: 10.1073/Pnas.1114854108 |
0.465 |
|
2011 |
Mathews DJ, Graff GD, Saha K, Winickoff DE. Access to stem cells and data: persons, property rights, and scientific progress. Science (New York, N.Y.). 331: 725-7. PMID 21311015 DOI: 10.1126/Science.1201382 |
0.407 |
|
2011 |
Saha K, Hurlbut JB. Disease modeling using pluripotent stem cells: making sense of disease from bench to bedside. Swiss Medical Weekly. 141: w13144. PMID 21308573 DOI: 10.4414/Smw.2011.13144 |
0.374 |
|
2010 |
Saha K, Kim J, Irwin E, Yoon J, Momin F, Trujillo V, Schaffer DV, Healy KE, Hayward RC. Surface creasing instability of soft polyacrylamide cell culture substrates. Biophysical Journal. 99: L94-6. PMID 21156124 DOI: 10.1016/J.Bpj.2010.09.045 |
0.57 |
|
2010 |
Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell. 143: 508-25. PMID 21074044 DOI: 10.1016/J.Cell.2010.10.008 |
0.45 |
|
2010 |
Mei Y, Saha K, Bogatyrev SR, Yang J, Hook AL, Kalcioglu ZI, Cho SW, Mitalipova M, Pyzocha N, Rojas F, Van Vliet KJ, Davies MC, Alexander MR, Langer R, Jaenisch R, et al. Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nature Materials. 9: 768-78. PMID 20729850 DOI: 10.1038/Nmat2812 |
0.46 |
|
2010 |
Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, Jaenisch R. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proceedings of the National Academy of Sciences of the United States of America. 107: 9222-7. PMID 20442331 DOI: 10.1073/Pnas.1004584107 |
0.425 |
|
2009 |
Saha K, Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell. 5: 584-95. PMID 19951687 DOI: 10.1016/J.Stem.2009.11.009 |
0.386 |
|
2009 |
Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP, van Oudenaarden A, Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature. 462: 595-601. PMID 19898493 DOI: 10.1038/Nature08592 |
0.43 |
|
2008 |
Saha K, Keung AJ, Irwin EF, Li Y, Little L, Schaffer DV, Healy KE. Substrate modulus directs neural stem cell behavior. Biophysical Journal. 95: 4426-38. PMID 18658232 DOI: 10.1529/Biophysj.108.132217 |
0.668 |
|
2008 |
Wall ST, Saha K, Ashton RS, Kam KR, Schaffer DV, Healy KE. Multivalency of Sonic hedgehog conjugated to linear polymer chains modulates protein potency. Bioconjugate Chemistry. 19: 806-12. PMID 18380472 DOI: 10.1021/Bc700265K |
0.504 |
|
2007 |
Saha K, Pollock JF, Schaffer DV, Healy KE. Designing synthetic materials to control stem cell phenotype. Current Opinion in Chemical Biology. 11: 381-7. PMID 17669680 DOI: 10.1016/J.Cbpa.2007.05.030 |
0.568 |
|
2007 |
Saha K, Irwin EF, Kozhukh J, Schaffer DV, Healy KE. Biomimetic interfacial interpenetrating polymer networks control neural stem cell behavior. Journal of Biomedical Materials Research. Part A. 81: 240-9. PMID 17236216 DOI: 10.1002/Jbm.A.30986 |
0.618 |
|
2006 |
Saha K, Schaffer DV. Signal dynamics in Sonic hedgehog tissue patterning. Development (Cambridge, England). 133: 889-900. PMID 16452094 DOI: 10.1242/Dev.02254 |
0.51 |
|
2004 |
Saha K, Schaffer D, Healy K. Bioactive hydrogels for control of stem cell function Transactions - 7th World Biomaterials Congress. 472. |
0.315 |
|
Show low-probability matches. |